Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia fergusonii UPF0352 protein yejL (yejL) CSB-YP482401EOR
CSB-EP482401EOR
CSB-BP482401EOR
CSB-MP482401EOR
CSB-EP482401EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii UPF0194 membrane protein ybhG (ybhG) CSB-YP482402EOR
CSB-EP482402EOR
CSB-BP482402EOR
CSB-MP482402EOR
CSB-EP482402EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii 50S ribosomal protein L34 (rpmH) CSB-YP482403EOR
CSB-EP482403EOR
CSB-BP482403EOR
CSB-MP482403EOR
CSB-EP482403EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii tRNA modification GTPase MnmE (mnmE) CSB-YP482404EOR
CSB-EP482404EOR
CSB-BP482404EOR
CSB-MP482404EOR
CSB-EP482404EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii D-ribose pyranase (rbsD) CSB-YP482405EOR
CSB-EP482405EOR
CSB-BP482405EOR
CSB-MP482405EOR
CSB-EP482405EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Chaperone protein hscA (hscA), partial CSB-YP482406EOR
CSB-EP482406EOR
CSB-BP482406EOR
CSB-MP482406EOR
CSB-EP482406EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii GTPase Der (der) CSB-YP482407EOR
CSB-EP482407EOR
CSB-BP482407EOR
CSB-MP482407EOR
CSB-EP482407EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC) CSB-YP482408EOR
CSB-EP482408EOR
CSB-BP482408EOR
CSB-MP482408EOR
CSB-EP482408EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii N-acetylmuramic acid 6-phosphate etherase (murQ) CSB-YP482409EOR
CSB-EP482409EOR
CSB-BP482409EOR
CSB-MP482409EOR
CSB-EP482409EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Potassium-transporting ATPase B chain (kdpB), partial CSB-YP482410EOR1
CSB-EP482410EOR1
CSB-BP482410EOR1
CSB-MP482410EOR1
CSB-EP482410EOR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Glycerol-3-phosphate acyltransferase (plsB), partial CSB-YP482411EOR
CSB-EP482411EOR
CSB-BP482411EOR
CSB-MP482411EOR
CSB-EP482411EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Putative ion-transport protein yfeO (yfeO), partial CSB-YP482412EOR
CSB-EP482412EOR
CSB-BP482412EOR
CSB-MP482412EOR
CSB-EP482412EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Penicillin-insensitive murein endopeptidase (mepA) CSB-YP482413EOR
CSB-EP482413EOR
CSB-BP482413EOR
CSB-MP482413EOR
CSB-EP482413EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Probable nicotinate-nucleotide adenylyltransferase (nadD) CSB-YP482414EOR
CSB-EP482414EOR
CSB-BP482414EOR
CSB-MP482414EOR
CSB-EP482414EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Enterobactin exporter EntS (entS), partial CSB-YP482415EOR
CSB-EP482415EOR
CSB-BP482415EOR
CSB-MP482415EOR
CSB-EP482415EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Elongation factor P (efp) CSB-YP482416EOR
CSB-EP482416EOR
CSB-BP482416EOR
CSB-MP482416EOR
CSB-EP482416EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Putative ribosome biogenesis GTPase RsgA (rsgA) CSB-YP482417EOR
CSB-EP482417EOR
CSB-BP482417EOR
CSB-MP482417EOR
CSB-EP482417EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii 3-keto-L-gulonate-6-phosphate decarboxylase UlaD (ulaD) CSB-YP482418EOR
CSB-EP482418EOR
CSB-BP482418EOR
CSB-MP482418EOR
CSB-EP482418EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii NADH-quinone oxidoreductase subunit B (nuoB) CSB-YP482419EOR
CSB-EP482419EOR
CSB-BP482419EOR
CSB-MP482419EOR
CSB-EP482419EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii o-succinylbenzoate synthase (menC) CSB-YP482420EOR
CSB-EP482420EOR
CSB-BP482420EOR
CSB-MP482420EOR
CSB-EP482420EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>